Navigation Links
Halozyme Therapeutics Reports First Quarter 2011 Financial Results
Date:5/6/2011

replay ID # 371588. The conference call will be broadcast live over the Internet at www.halozyme.com and the replay will be available on the company's Web site for seven days.

About Halozyme TherapeuticsHalozyme Therapeutics is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets. The company's product portfolio is based primarily on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes that affect the extracellular matrix. Halozyme's Enhanze™ technology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. The company has key partnerships with Roche and with Baxter to apply Enhanze technology to biological therapeutics including Herceptin®, MabThera® and immunoglobulin. Halozyme's Ultrafast Insulin program combines its rHuPH20 enzyme with mealtime insulins, which may produce more rapid absorption, faster action, and improved glycemic control. The product candidates in Halozyme's pipeline target multiple areas of significant unmet medical need. For more information visit www.halozyme.com.

Safe Harbor Statement In addition to historical information, the statements set forth above include forward-looking statements (including, without limitation, statements concerning the timing and scope of our clinical trials as well as expected activities under our collaborative partnerships) that involve risk and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. The forward-looking statemen
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Halozymes Ultrafast Insulin Generates Faster-In and Faster-Out Profile for Type 1 Diabetes Patients Using Insulin Pumps
2. Halozyme Announces Roche Doses First Patient in Phase 3 Clinical Trial With Subcutaneous MabThera® (rituximab)
3. Halozyme Therapeutics Reports Third Quarter 2010 Financial Results
4. Halozyme Receives $5.5 Million Payment From Baxter
5. Halozyme Therapeutics Reports 2008 Third Quarter Financial Results
6. Halozyme Therapeutics Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients
7. Halozyme Therapeutics Announces Conference Call on November 6 to Review Third Quarter Results
8. Halozyme Therapeutics to Present at Upcoming Investor Conferences
9. Halozyme Therapeutics to Host Research Day for Investors and Analysts
10. Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
11. Halozyme Therapeutics to Present at Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Nobel laureate Herbert Kroemer famously observed, referring to ... junctures where layers of different materials meet. In ... layers of metal oxides are becoming increasingly prominent, ... high-temperature superconductors, ferroelectrics and multiferroics. Realizing the vast ...
(Date:1/15/2014)... The Pittcon Organizing Committee is pleased to ... Tech , an e-Journal and producer of Food ... second year for the co-location of Food Labs Conference to ... that the registration fee to attend the two-day Food Lab ...
(Date:1/15/2014)... 2014 Look inside the new Preferred ... the lab, from fluid handling to instruments to supplies. ... when you order. , Preferred Solutions features a ... the L/S® model for precise flow control and dispensing ...
(Date:1/15/2014)... and SAN JOSE, California , January 15, ... developing antibody-drug conjugates for cancer, today announced the appointment of ... Dr Reynolds has over 20 years, development experience gained in ... Seattle Genetics. "I am delighted to welcome Tom ...
Breaking Biology Technology:A deeper look at interfaces 2Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3
... announced on Sunday they have successfully created embryonic stem ... affect some of the ethical debate over their use ... Wisconsin-Madison professor cautions that the breakthrough has limited repercussions. ... of the research journal Science, researchers Chad ...
... made significant progress in improving business conditions in the ... restrictions if the state is to better capitalize on ... , ,"Today it is easier to legally gamble your ... emerging, growth Wisconsin companies," said Terry Grosenheider, a US ...
... is the first in a new UW E-Business Consortium ... of Wisconsin E-Business Consortium in 2002. , ,People ... appliance design. The brand those valued consumers turn to ... built-in refrigeration units can be seamlessly integrated to match ...
Cached Biology Technology:Harvard advance improves stem cell research; not a medical revolution 2Regulations still stymie business investment in high-growth companies 2Regulations still stymie business investment in high-growth companies 3Regulations still stymie business investment in high-growth companies 4How Sub-Zero Freezer Co. uses technology to revolutionize customer service 2How Sub-Zero Freezer Co. uses technology to revolutionize customer service 3
(Date:7/10/2014)... or GOES-West satellite spotted smoke over the U.S. ... Northwestern Territories. , At 1200 UTC (8 a.m. ... image of the brownish-colored haze created by forest ... the way into South Dakota. This image was ... Goddard Space Flight Center, Greenbelt, Md. , ...
(Date:7/10/2014)... organization funding cutting-edge, innovative research on Alzheimer,s disease ... degeneration, today announced the recipients of new research ... U.S. states, the District of Columbia, and five ... With these latest grants, BrightFocus has now provided ... 2014. , The research projects funded this year ...
(Date:7/10/2014)... currents in the Straits of Mackinac reverse direction every ... the channel would quickly contaminate shorelines miles away in ... University of Michigan study commissioned by the National Wildlife ... and accompanying animations, oil from a hypothetical pipeline break ... and Bois Blanc Island after two days. All three ...
Breaking Biology News(10 mins):BrightFocus Foundation announces 55 new grantees in Alzheimer's and vision research 2BrightFocus Foundation announces 55 new grantees in Alzheimer's and vision research 3Straits of Mackinac 'worst possible place' for a Great Lakes oil spill 2Straits of Mackinac 'worst possible place' for a Great Lakes oil spill 3
... NEW YORK (Jan. 20, 2010) -- In a significant ... variety of diseases, a team of scientists at Weill ... described a novel mechanism for turning human embryonic and ... are critical to the formation of blood vessels. Endothelial ...
... seed money from the National Science Foundation (NSF), bioengineers ... are ramping up efforts to characterize the thousands of ... that eventually, researchers can mix and match these "DNA ... or chemicals. Today, a single designer microbe can ...
... available in French . , Chicken sold in ... risk of urinary tract infections (UTI), McGill researcher Amee Manges ... and 2007, in collaboration with the Public Health Agency of ... that E. coli ( Escherichia coli ) bacteria ...
Cached Biology News:New way to generate abundant functional blood vessel cells from human stem cells discovered 2New way to generate abundant functional blood vessel cells from human stem cells discovered 3New way to generate abundant functional blood vessel cells from human stem cells discovered 4NSF grant to launch world's first open-source genetic parts production facility 2NSF grant to launch world's first open-source genetic parts production facility 3NSF grant to launch world's first open-source genetic parts production facility 4Retail meat linked to urinary tract infections: Strong new evidence 2
... System creates isogenic cell lines all ... the protein of interest. This homogeneous ... (click link below). In this experiment ... (CAT) was subcloned into pcDNA5/FRT and ...
Fast, sensitive quantitation of total MEK 1/2 concentration....
... for 50 L samples. Operating head automatically rises at the end of determination; triple-point calibration verification; refrigerator ... ... ... ...
SHEEP ANTI ESCHERICHIA COLI...
Biology Products: